Palisade Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-18,100
| Closed | -$319K | – | 450 |
|
|
2017
Q3 | $319K | Buy |
18,100
+2,578
| +17% | +$45.4K | 0.01% | 385 |
|
|
2017
Q2 | $516K | Sell |
15,522
-2,000
| -11% | -$66.5K | 0.02% | 377 |
|
|
2017
Q1 | $562K | Sell |
17,522
-4,100
| -19% | -$132K | 0.02% | 362 |
|
|
2016
Q4 | $784K | Buy |
21,622
+5,600
| +35% | +$203K | 0.03% | 355 |
|
|
2016
Q3 | $737K | Buy |
16,022
+3,500
| +28% | +$161K | 0.03% | 452 |
|
|
2016
Q2 | $629K | Buy |
+12,522
| New | +$629K | 0.02% | 448 |
|
|
2014
Q3 | – | Sell |
-65,722
| Closed | -$3.45M | – | 494 |
|
|
2014
Q2 | $3.45M | Sell |
65,722
-9,300
| -12% | -$487K | 0.08% | 300 |
|
|
2014
Q1 | $3.96M | Sell |
75,022
-8,500
| -10% | -$449K | 0.1% | 278 |
|
|
2013
Q4 | $3.35M | Buy |
+83,522
| New | +$3.35M | 0.09% | 284 |
|